Finland
· Delayed Price · Currency is EUR Herantis Pharma Oyj Statistics
Total Valuation
HEL:HRTIS has a market cap or net worth of EUR 32.65 million. The enterprise value is 30.59 million.
| Market Cap | 32.65M |
| Enterprise Value | 30.59M |
Important Dates
The next estimated earnings date is Thursday, August 21, 2025.
| Earnings Date | Aug 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HEL:HRTIS has 24.09 million shares outstanding. The number of shares has increased by 17.25% in one year.
| Current Share Class | 24.09M |
| Shares Outstanding | 24.09M |
| Shares Change (YoY) | +17.25% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 10.05% |
| Owned by Institutions (%) | 48.90% |
| Float | 17.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -134.40 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.19 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.06
| Current Ratio | 4.06 |
| Quick Ratio | 4.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10,649.34 |
Financial Efficiency
Return on equity (ROE) is -220.33% and return on invested capital (ROIC) is -136.82%.
| Return on Equity (ROE) | -220.33% |
| Return on Assets (ROA) | -67.44% |
| Return on Invested Capital (ROIC) | -136.82% |
| Return on Capital Employed (ROCE) | -259.43% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -449,024 |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.21% in the last 52 weeks. The beta is 0.32, so HEL:HRTIS's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | -6.21% |
| 50-Day Moving Average | 1.39 |
| 200-Day Moving Average | 1.46 |
| Relative Strength Index (RSI) | 44.90 |
| Average Volume (20 Days) | 10,132 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -5.03M |
| Pretax Income | -4.94M |
| Net Income | -4.94M |
| EBITDA | n/a |
| EBIT | -5.03M |
| Earnings Per Share (EPS) | -0.24 |
Balance Sheet
The company has 2.13 million in cash and 73,972 in debt, giving a net cash position of 2.06 million or 0.09 per share.
| Cash & Cash Equivalents | 2.13M |
| Total Debt | 73,972 |
| Net Cash | 2.06M |
| Net Cash Per Share | 0.09 |
| Equity (Book Value) | -242,914 |
| Book Value Per Share | -0.01 |
| Working Capital | 1.94M |
Cash Flow
| Operating Cash Flow | -6.55M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HEL:HRTIS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.25% |
| Shareholder Yield | -17.25% |
| Earnings Yield | -15.13% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |